About BMRN Dividend Returns
BioMarin Pharmaceutical Inc. (BMRN) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of BMRN over the past year?
BioMarin Pharmaceutical Inc. (BMRN) delivered a return of -13.25% over the past year. Since BMRN does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in BMRN be worth today?
A $10,000 investment in BioMarin Pharmaceutical Inc. one year ago would be worth $8,675 today, representing a loss of $1,325.
Q3Does BMRN pay dividends?
BioMarin Pharmaceutical Inc. (BMRN) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For BMRN, the total return equals the price-only return.
Q4Did BMRN beat the S&P 500?
No, BioMarin Pharmaceutical Inc. (BMRN) underperformed the S&P 500 by 28.70 percentage points over the past year. BMRN delivered a total return of -13.25%, compared to the S&P 500's 15.45%. This means a passive S&P 500 index fund outperformed BMRN by 28.70pp during this period.
Q5What is BMRN's worst drawdown?
BioMarin Pharmaceutical Inc. (BMRN) experienced a maximum drawdown of -29.34% over the past year, declining from its peak on 2025-03-27 to its trough on 2025-11-07. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is BMRN's long-term total return over 10, 20, or 30 years?
BioMarin Pharmaceutical Inc. (BMRN) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is -24.6% (-2.8% CAGR) — $10,000 would have grown to $7,540. Over 20 years: 371.9% total return (8.1% CAGR) — $10,000 → $47,194. Over 30 years: 370.1% total return (5.3% CAGR) — $10,000 → $47,015. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was BMRN's best and worst year?
BioMarin Pharmaceutical Inc.'s best calendar year was 2007 with a total return of 119.9%. Its worst year was 2008 with a total return of -51.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 171.3 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).